Drug companies should not have the final say in the design of clinical trials

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of kidney diseases 2001-11, Vol.38 (5), p.1113-1114
1. Verfasser:	Kurtzman, Neil A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - therapeutic use Biphenyl Compounds - therapeutic use Clinical Trials as Topic - standards Diabetes Mellitus, Type 2 - complications Diabetic Nephropathies - economics Diabetic Nephropathies - etiology Diabetic Nephropathies - prevention & control Drug Industry Enalapril - therapeutic use Humans Losartan - therapeutic use Research Design - standards Tetrazoles - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!